Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04640766 · ClinicalTrials.gov registry record · NA
Process-instructed Self Neuro-Modulation (PRISM) for Attention Deficit/ Hyperactivity Disorder - Adults
A NA study of Attention Deficit Hyper Activity, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT04640766 is a NA study of Attention Deficit Hyper Activity that has completed, run by NYU Langone Health. The registered enrollment target is 18 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04640766, a NA study of Attention Deficit Hyper Activity, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-arm, open-label feasibility study. Participants will be assigned and will undergo a novel neurofeedback intervention, targeting down-regulation of deep limbic structures, specifically the amygdalae. Participants will complete 12 neurofeedback sessions delivered twice weekly over 6 consecutive weeks. The intervention will be delivered via the PRISM platform.
Conditions Studied
Interventions
- DEVICE PRISM
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2021-07-26 |
| Est. Completion | 2022-10-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04640766
The ClinicalTrials.gov registry entry for NCT04640766 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Attention Deficit Hyper Activity appearing as the primary indexed condition, and to 1 intervention - of which PRISM is the first listed.
NCT04640766 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04640766 about?
NCT04640766 is a clinical study titled "Process-instructed Self Neuro-Modulation (PRISM) for Attention Deficit/ Hyperactivity Disorder - Adults". This is a single-arm, open-label feasibility study. Participants will be assigned and will undergo a novel neurofeedback intervention, targeting down-regulation of deep limbic structures, specifically the amygdalae. Participants will complete 12 neurofeedback sessions delivered twice weekly over 6 c...
What is the current status of trial NCT04640766?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2021-07-26. Estimated completion is 2022-10-18.
What conditions does trial NCT04640766 study?
This clinical trial studies the following conditions: Attention Deficit Hyper Activity.
What interventions are being tested in trial NCT04640766?
The interventions under investigation include: PRISM (DEVICE).
Who is sponsoring clinical trial NCT04640766?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04640766 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.